Le Lézard
Classified in: Science and technology, Business
Subjects: ERN, ACC

Crayon reports 24% gross profit increase in Q3


OSLO, Norway, Nov. 8, 2023 /PRNewswire/ -- Crayon Group Holding ASA (OSE: CRAYN), a global leader in IT services and innovation, today reported its third-quarter results with a gross profit growth of 24%, reflecting the continued strong demand for software and cloud services.

"The market demand remains solid and is demonstrated by our Gross Profit performance," said Crayon CEO Melissa Mulholland. "When we look across our 46 markets, we see companies continuing to increase investments in digitalization and even more importantly, preparing their IT estate for serving the rapid transformation AI will bring with the availability of technologies such as Microsoft Copilot and Google Duet."

Microsoft 365 Copilot is a new AI-powered productivity tool designed to revolutionize the way businesses operate. Google Duet is the AI-fueled collaborator across Google Cloud.

"We remain positive to the long-term opportunities from AI and are well-positioned to take advantage of them as we were one of the partners Microsoft selected to have early access to Copilot in order to help launch one of their key products," she said.

Gross profit growth remains solid mainly driven by continuous strong performance in both the Nordics and Europe. From a business area perspective, Crayon delivered solid growth across all segments, with particularly strong performance in Software and Cloud Channel.

Financial highlights:

Gross Profit  NOK 1, 262m  Up 24% (16% in constant currency)

Adjusted EBITDA  NOK  143m  Up 27% (+ 30m)

Net Profit  NOK  -13m    Up 84% (+ 67m)

CONTACT: 
Melanie Coffee
VP of PR and Communications
[email protected]
+47 46 74 86 48

 


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...

at 20:00
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: